France
Core Biogenesis is an innovative company founded in 2020, situated at the forefront of the Biotechnology, Life Sciences, and Pharmaceutical industries. Headquartered in France, the company is pioneering advancements in recombinant protein bioproduction specifically tailored for Regenerative Medicine & Skincare.
The company's forward-thinking approach is encapsulated in its slogan: "The future of recombinant protein bioproduction for Regenerative Medicine & Skincare." This emphasis positions Core Biogenesis as a pivotal player in the next generation of bioproduction technologies.
In terms of financial backing, the most recent boost includes a significant €10.00M Grant investment on 01 March 2022. Prestigious investors like Blue Horizon, Entrepreneur First, XAnge, Blue Horizon Equity, and Thia Ventures have shown confidence in the company's potential. This financial and strategic support places Core Biogenesis in a strong position as it navigates and capitalizes on growth opportunities in its target markets.
